Category evidence review
Best NAD+ Boosters Compared: NMN vs NR (Nicotinamide Riboside) — Honest Evidence Review with Zero Elite Products in the Category
NAD+ precursors — NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) — are the poster child of the longevity supplement conversation. David Sinclair's popularization made both household terms. What the RCT evidence actually shows: NR reliably raises whole-blood NAD+ levels at 300-1,000 mg/day (Martens 2018 Nature Communications; Airhart 2017; Trammell 2016). NMN shows similar biomarker effects at 250-1,000 mg/day. What the evidence does NOT clearly show as of 2026: meaningful downstream clinical endpoints in healthy adults (functional performance, disease outcomes, longevity biomarkers beyond NAD+ itself). Additionally, FDA's 2022 position on NMN classification remains unsettled — declared not a legal dietary ingredient in some communications, enforcement inconsistent. This ranks the top-scoring NAD+ boosters in our catalog on Evidence (RCT support for downstream outcomes, not just biomarker uplift), Formulation, Manufacturing, Safety, Transparency, and Sustainability. Read the rubric →
NMN vs NR — what the RCT record actually shows
| NMN (Nicotinamide Mononucleotide) | NR (Nicotinamide Riboside — Niagen) | |
|---|---|---|
| Biomarker uplift (raises blood NAD+) | Yes at 250-1,000 mg/day (Yamane 2020, Yoshino 2021) | Yes at 300-1,000 mg/day (Trammell 2016, Martens 2018) |
| Clinical endpoint RCT support in healthy adults | Very limited — mostly biomarker + surrogate endpoints | Limited — mostly biomarker + surrogate endpoints |
| Safety profile | Generally well tolerated at studied doses | Generally well tolerated at studied doses |
| FDA regulatory status (US, 2026) | Uncertain — declared not a legal dietary ingredient in some FDA communications; enforcement inconsistent | NDI-approved dietary ingredient |
| Third-party testing availability | Variable — some brands publish COAs, many do not | Tru Niagen (patented Niagen NR) publishes COAs + has the majority of NR RCT literature attached to it |
| Cost per gram (retail) | Similar to NR when comparing pure NMN | Similar to NMN when comparing pure NR |
Honest take: both raise NAD+ levels. Neither has convincing clinical-endpoint RCT support in healthy adults yet. Zero products in the entire NAD+ booster category cleared Elite tier on our rubric. The top-scored product is Tru Niagen 300 mg NR at 78/100 Verified — the ingredient with the strongest brand-tied RCT literature and regulatory clarity. If you're going to try NAD+ supplementation, treat it as an experiment, not a foundational must-have. See our Foundational Biohacking Stack for what the rubric-anchored core is.
Head-to-head summary
Top score: Tru Niagen - Niagen 300 mg Nikotinamid Ribosid Supplement for Anti-Aging & Cellular Energy Support - 30 Capsules at 78/100 — see the deep-dive for the reasoning.
Per-product deep dive
#1 Tru Niagen - Niagen 300 mg Nikotinamid Ribosid Supplement for Anti-Aging & Cellular Energy Support - 30 Capsules78/100 · Verified
Tru Niagen 300mg — Niagen is ChromaDex's proprietary nicotinamide riboside (NR) with the most extensive human RCT literature of any NAD+ precursor (Martens 2018, Airhart 2017, Trammell 2016 on NAD+ elevation, PK, and safety). Regulatory advantage over NMN: NR has GRAS-affirmed status with FDA. Tru Niagen is the licensed consumer brand with real quality controls and transparent supply chain. 300mg is in the studied dose range. Held below Elite by (1) sold via a third-party reseller — buy direct from Tru Niagen for full brand-quality documentation; (2) sustainability profile thin; (3) higher per-serving cost than generic NAD-precursor products. Would move to Elite 85+ with direct-brand purchase channel + sustainability certification. Higher-scoring product in the NAD+ precursor category vs the NMN alternatives (see /blogs/news/nmn-gmp-certified-what-to-check-buyers-guide for the full NR-vs-NMN discussion).
#2 NMN Supplement 1000 mg | 99.9% Pure BONTAC® β-NMN | Made in Japan76/100 · Verified
Novera NMN 30,000 pushes the transparency envelope for the NAD+-precursor category. The formula uses BONTAC beta-NMN — a raw-material identity whose provenance is publicly documented; the same source has appeared in peer-reviewed preclinical work co-authored by a Harvard Medical School researcher (see the brand's linked evidence page). Dose is fully disclosed at 500 mg per capsule and 1,000 mg per serving (2 capsules), the finished product is manufactured in Japan under international GMP, each lot carries a batch-level 99.9%-purity certificate, and Novera includes a Certificate of Free Sale from the Japanese government — verification pathways almost no U.S. competitor exposes. Vegan HPMC capsule, 60 caps/30 servings, 30-day money-back. The catch — and it is a real one for a scoring rubric that rewards transparency — is regulatory: FDA communications in 2022 asserted that NMN cannot be marketed as a dietary supplement in the U.S. because it had been previously authorized for investigation as a drug. Enforcement has been inconsistent and NMN remains widely sold, but a fully honest score has to acknowledge that the U.S. legal status is unsettled. Held to Verified rather than Elite on that regulatory uncertainty plus the ordinary NAD+-precursor evidence gap (RCT endpoints for NMN in humans are still largely biomarker-only, not hard outcome).
See the full NMN Supplement 1000 mg | 99.9% Pure BONTAC® β-NMN | Made in Japan page →
#3 Life Extension NAD+ Cell Regenerator74/100 · Verified
[Rescored via evidence crawl] Previous score 62 → new 74. Evidence found: Trammell SA et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016;7:12948. | Martens CR et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nat Commun. 2018;9:1286. | Airhart SE et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside in humans. PLoS One. 2017;12(12):e0186459.. Rationale: LE NAD+ Cell Regenerator uses NIAGEN (Chromadex-branded nicotinamide riboside), the same NR compound with published PK and safety data in humans (Trammell 2016, Martens 2018). NR reliably elevates whole-blood NAD+ by 40-60% at 300 mg/day. Uplift to Verified — capped below 80 because clinical-endpoint trials (aging, cardiometabolic outcomes) remain limited to biomarker studies.
#4 Qualia NAD Supplement73/100 · Verified
Neurohacker Collective (parent of Qualia) has an unusually strong R&D discipline for the supplement space — they routinely commission and publish their own randomized placebo-controlled trials on Qualia formulations. Qualia NAD+ combines three NAD+ precursors (NR + niacinamide + additional pathway support) at published-trial doses. Two randomized double-blind placebo-controlled trials on Qualia NAD have been publicly referenced by Neurohacker; the underlying NR / NAD+ precursor literature (Martens 2018, Airhart 2017, Trammell 2016) is strong. Held below Elite by (1) the two DB-RCTs referenced are Neurohacker-funded rather than fully independent; (2) three-precursor blend adds formulation complexity vs single-active NR products (Tru Niagen) that have larger independent literature; (3) no publicly-posted third-party COA for NR content; (4) sustainability profile thin. Would move to Elite 85+ with independently-replicated efficacy trial + public COA.
#5 Life Extension NAD+ Cell Regenerator 300 mg Energy Support 30 Caps72/100 · Verified
A clean, single-ingredient nicotinamide riboside formula at a clearly disclosed 300 mg dose, which sits within the range used in published human NAD+-boosting research.
See the full Life Extension NAD+ Cell Regenerator 300 mg Energy Support 30 Caps page →
#6 NAD+ Cell Support NMN 300mg – 90 Veggie Caps | Cellular Energy & Healthy Aging | Life Extension71/100 · Verified
Life Extension is a long-established, GMP-audited manufacturer with a track record of standardized formulations, and this product's 300mg NMN dose sits within the range used in recent human NAD+-elevation trials. Evidence for NMN's healthy-aging benefits is still emerging: several small human studies show it raises blood NAD+ levels, but robust long-term outcome data in humans remains limited, and NMN's status as a dietary ingredient has been contested by the FDA. No sustainability disclosures were found on this listing, so that dimension defaults to the rubric's neutral baseline.
#7 NMN 500mg | NAD+ Booster for Cellular Energy & Peak Performance67/100 · Standard
Halea Life discloses a clean, single-ingredient 500mg NMN formula with only three additional excipients and no proprietary blend, and 500mg sits within the roughly 250-900mg range used in published human NMN trials, so the dose itself is credible rather than under- or over-dosed. NMN's human evidence base is moderate and still developing relative to more established longevity ingredients. No third-party manufacturing certification or facility detail is disclosed, which limits build-quality confidence, and sustainability information is not provided.
See the full NMN 500mg | NAD+ Booster for Cellular Energy & Peak Performance page →
#8 Optimized NAD+ NMN 300mg with Resveratrol Elite™ – 30 Veggie Caps | Cellular Aging Support | Life Extension64/100 · Standard
Life Extension manufactures this longevity-focused formula under established cGMP standards, and the core NMN dose of 300mg is within the range used in current human research on raising NAD+ levels — an active and promising but still-developing area of science. The 'Resveratrol Elite' component is a named proprietary blend, though it does disclose that trans-resveratrol makes up roughly 10mg of the 55mg blend, a dose notably below the 150-500mg range used in most resveratrol clinical trials. Overall this lands as Standard: solid manufacturing credibility offset by emerging (not yet fully established) evidence and a resveratrol dose likely too low to match its own research base.
How the scoring works
Every product is scored on six dimensions — evidence (RCT quality supporting the active ingredients at the label dose), formulation (dose adequacy, bioavailability form, redundancy), manufacturing (third-party testing, GMP, facility audits), safety (adverse-event profile, interactions, dose ceiling), transparency (dose disclosure vs proprietary blends, honest marketing), and sustainability (sourcing, packaging, corporate practice). Tier thresholds: Elite 85+, Verified 70–84, Standard 50–69, Rejected 0–49. Rejected products stay listed with reasons. Full rubric →